Little Chip in the Big Apple!
Thursday September 25, 9:24 am ET
New York City's first subdermal RFID VeriChip ``chipping'' procedure performed yesterday at lower Manhattan Authorized VeriChip Center
Journalist researching a story about RFID technologies undergoes brief outpatient procedure at the office of Dr. Christopher Mills and Dr. Vincent Scarpinato
PALM BEACH, Fla.--(BUSINESS WIRE)--Sept. 25, 2003-- Applied Digital Solutions, Inc. (Nasdaq: ADSX - News), an advanced technology development company, today announced that New York City's first subdermal VeriChip(TM) "chipping" procedure was performed yesterday (September 24, 2003) at the Company's lower Manhattan Authorized VeriChip Center.
A journalist at a technology-related trade publication decided to Get Chipped(TM) in researching an upcoming article regarding RFID (radio frequency identification) technologies, including VeriChip. The lower Manhattan Authorized VeriChip Center is located in the office of Dr. Christopher Mills and Dr. Vincent Scarpinato, 88 University Place, New York City (Tel: 646-486-0871).
The brief outpatient "chipping" procedure lasts just a few minutes and involves only local anesthetic followed by quick, painless insertion of the VeriChip. About the size of a grain of rice, the subdermal RFID VeriChip can be used in a variety of security, financial, emergency identification and other applications. The standard location of the microchip is in the triceps area between the elbow and the shoulder of the right arm. Once inserted just under the skin, the VeriChip is inconspicuous to the naked eye.
About VeriChip(TM)
VeriChip is a subdermal, radio frequency identification (RFID) device that can be used in a variety of security, financial, emergency identification and other applications. About the size of a grain of rice, each VeriChip product contains a unique verification number that is captured by briefly passing a proprietary scanner over the VeriChip. A small amount of radio frequency energy passes from the scanner energizing the dormant VeriChip, which then emits a radio frequency signal transmitting the verification number. In October 2002, the US Food and Drug Administration (FDA) ruled that VeriChip is not a regulated device with regard to its security, financial, personal identification/safety applications but that VeriChip's healthcare information applications are regulated by the FDA. VeriChip Corporation is a wholly owned subsidiary of Applied Digital Solutions (Nasdaq: ADSX - News). For more information about VeriChip, visit www.adsx.com.
About Applied Digital Solutions, Inc.
Applied Digital Solutions is an advanced technology development company that focuses on a range of life-enhancing, personal safeguard technologies, early warning alert systems, miniaturized power sources and security monitoring systems combined with the comprehensive data management services required to support them. Through its Advanced Technology Group, the Company specializes in security-related data collection, value-added data intelligence and complex data delivery systems for a wide variety of end users including commercial operations, government agencies and consumers. Applied Digital Solutions owns a majority position in Digital Angel Corporation (AMEX: DOC - News). For more information, visit the Company's website at www.adsx.com.
Statements about the Company's future expectations, including future revenues and earnings, and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and the Company's actual results could differ materially from expected results. The Company undertakes no obligation to update forward-looking statements to reflect subsequently occurring events or circumstances.
--------------------------------------------------------------------------------
Contact:
CEOcast, Inc.
Investor Contact: Ken Sgro, 212-732-4300
[email protected]
or
Ovations International, Inc.
Media Contact: Matthew Cossolotto, 914-245-9721
[email protected]
Thursday September 25, 9:24 am ET
New York City's first subdermal RFID VeriChip ``chipping'' procedure performed yesterday at lower Manhattan Authorized VeriChip Center
Journalist researching a story about RFID technologies undergoes brief outpatient procedure at the office of Dr. Christopher Mills and Dr. Vincent Scarpinato
PALM BEACH, Fla.--(BUSINESS WIRE)--Sept. 25, 2003-- Applied Digital Solutions, Inc. (Nasdaq: ADSX - News), an advanced technology development company, today announced that New York City's first subdermal VeriChip(TM) "chipping" procedure was performed yesterday (September 24, 2003) at the Company's lower Manhattan Authorized VeriChip Center.
A journalist at a technology-related trade publication decided to Get Chipped(TM) in researching an upcoming article regarding RFID (radio frequency identification) technologies, including VeriChip. The lower Manhattan Authorized VeriChip Center is located in the office of Dr. Christopher Mills and Dr. Vincent Scarpinato, 88 University Place, New York City (Tel: 646-486-0871).
The brief outpatient "chipping" procedure lasts just a few minutes and involves only local anesthetic followed by quick, painless insertion of the VeriChip. About the size of a grain of rice, the subdermal RFID VeriChip can be used in a variety of security, financial, emergency identification and other applications. The standard location of the microchip is in the triceps area between the elbow and the shoulder of the right arm. Once inserted just under the skin, the VeriChip is inconspicuous to the naked eye.
About VeriChip(TM)
VeriChip is a subdermal, radio frequency identification (RFID) device that can be used in a variety of security, financial, emergency identification and other applications. About the size of a grain of rice, each VeriChip product contains a unique verification number that is captured by briefly passing a proprietary scanner over the VeriChip. A small amount of radio frequency energy passes from the scanner energizing the dormant VeriChip, which then emits a radio frequency signal transmitting the verification number. In October 2002, the US Food and Drug Administration (FDA) ruled that VeriChip is not a regulated device with regard to its security, financial, personal identification/safety applications but that VeriChip's healthcare information applications are regulated by the FDA. VeriChip Corporation is a wholly owned subsidiary of Applied Digital Solutions (Nasdaq: ADSX - News). For more information about VeriChip, visit www.adsx.com.
About Applied Digital Solutions, Inc.
Applied Digital Solutions is an advanced technology development company that focuses on a range of life-enhancing, personal safeguard technologies, early warning alert systems, miniaturized power sources and security monitoring systems combined with the comprehensive data management services required to support them. Through its Advanced Technology Group, the Company specializes in security-related data collection, value-added data intelligence and complex data delivery systems for a wide variety of end users including commercial operations, government agencies and consumers. Applied Digital Solutions owns a majority position in Digital Angel Corporation (AMEX: DOC - News). For more information, visit the Company's website at www.adsx.com.
Statements about the Company's future expectations, including future revenues and earnings, and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and the Company's actual results could differ materially from expected results. The Company undertakes no obligation to update forward-looking statements to reflect subsequently occurring events or circumstances.
--------------------------------------------------------------------------------
Contact:
CEOcast, Inc.
Investor Contact: Ken Sgro, 212-732-4300
[email protected]
or
Ovations International, Inc.
Media Contact: Matthew Cossolotto, 914-245-9721
[email protected]
